Microbial GAA Production via Enzyme Pathway Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods do not effectively enhance the production of guanidinoacetic acid (GAA) in microorganisms like E. coli and Corynebacterium glutamicum, particularly in providing glycine as a starting material for GAA biosynthesis, limiting the efficiency of creatine production.
Innovation Solution
A microorganism is engineered to overexpress genes encoding L-arginine:glycine amidinotransferase and glyoxylate aminotransferase, with increased enzymatic activities of carbamoylphosphate synthase, ornithine carbamoyltransferase, argininosuccinate synthetase, and argininosuccinate lyase, while decreasing malate synthase activity, to improve GAA production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If microorganisms are engineered to overexpress L-arginine:glycine amidinotransferase and related enzymes, then GAA production is enhanced, but the complexity of metabolic pathway engineering increases
Solution Approach 1:
The metabolic engineering approach is segmented into distinct enzymatic steps: overexpressing L-arginine:glycine amidinotransferase (AGAT) for the key amidinotransferase reaction, carbamoylphosphate synthase for carbamoyl phosphate production, ornithine carbamoyltransferase for citrulline formation, argininosuccinate synthetase and lyase for arginine biosynthesis, and separately controlling malate synthase. This segmentation allows targeted optimization of each pathway component independently.
Solution Approach 2:
The invention applies parameter changes by modifying enzyme activities through genetic engineering - increasing the expression levels and catalytic activities of specific enzymes (AGAT, carbamoylphosphate synthase, ornithine carbamoyltransferase, argininosuccinate synthetase, argininosuccinate lyase) while decreasing malate synthase activity. These parameter changes in enzymatic activities directly enhance GAA production efficiency.
2Productivity
If glycine supply is increased for GAA biosynthesis, then creatine production is improved, but the metabolic burden on the microorganism increases
Solution Approach 1:
The microorganism is pre-engineered with enhanced glycine biosynthesis capacity through overexpression of glyoxylate aminotransferase and related enzymes before GAA production. This preliminary action ensures充足的 glycine supply is already in place, reducing the metabolic burden during actual GAA and creatine production phases.
Solution Approach 2:
The invention uses arginine as an intermediary substrate that connects glycine metabolism to GAA production. By enhancing the arginine biosynthesis pathway (through carbamoylphosphate synthase, ornithine carbamoyltransferase, argininosuccinate synthetase and lyase), the system efficiently converts metabolic precursors into arginine, which then serves as the amino donor for AGAT-catalyzed GAA formation, thereby indirectly supporting glycine supply without direct glycine overproduction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered microorganism significantly increases GAA production by optimizing the enzymatic pathways involved in GAA biosynthesis, leading to enhanced creatine production through a fermentative process.
Implementation Method 1
L-arginine:glycine amidinotransferase (AGAT; EC 2.1.4.1), which is the first step in creatine biosynthesis
Implementation Method 2
protein having the function of a glyoxylate aminotransferase
Implementation Method 3
method for the fermentative production of GAA using such microorganism
Data Source
AI summary
A microorganism is transformed to be capable of producing guanidinoacetic acid (GAA). A method can be used for the fermentative production of GAA using such a microorganism. A corresponding method can be used for the fermentative production of creatine.